LENZ Therapeutics Statistics
NASDAQ: LENZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.97-0.375 (-11.23%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LENZ Therapeutics by the numbers
LENZ Therapeutics has a market capitalization of $93.2 million based on 31.42M shares outstanding. With trailing EPS of $-4.53, LENZ Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.3% below its 50-day average and 57.3% below its 200-day average.
Average daily trading volume is 892.30K shares, or about $2.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LENZ valuation vs. peer median
| Metric | LENZ | Peer median | Difference |
|---|---|---|---|
| Market cap | $93.16M | $95.83M | -3% |
| Avg. volume | 892.30K | 986.10K | -10% |
Peer median across 8 companies: OTLK, VYGR, IPHA, ZURA, MOLN, CRDL, BDTX, FATE.
Valuation
- Market cap
- $93.16M
- Price / sales (latest FY)
- 4.88
- EPS (TTM)
- $-4.53
- Shares outstanding
- 31.42M
Price and trading
- Previous close
- 3.34
- Open
- 3.22
- Day range
- 2.82 – 3.44
- 52-week range
- 2.80 – 32.13
- 52-week change
- -89.97%
- Beta
- —
- Volume
- 951.16K
- Average volume
- 892.30K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 93.16M
- Forward Pe
- -2.46
- Eps
- -4.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 32.13
- Week52 Low
- 2.80
- Avg Volume
- 892.30K
- Shares Outstanding
- 31.42M
- Ma50
- 3.63
- Ma200
- 6.94
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -90.77%
- Pct From52w Low
- 5.89%